<DOC>
	<DOCNO>NCT02447289</DOCNO>
	<brief_summary>Randomised clinical trial test efficacy , safety cost-effectiveness sedative ; mask , control , parallel design three arm , phase 4 .</brief_summary>
	<brief_title>Midazolam Ketamine Effect Administered Through Nose Sedation Children Dental Treatment</brief_title>
	<detailed_description>About 10 % child may behavioral problem dental treatment , evidence sedative protocol benefit care pediatric dentistry still weak . This randomized , mask , control , parallel design study aim evaluate efficacy , safety cost-effectiveness intranasal sedation ketamine / midazolam healthy child age 2 6 year old . Children select among dental decay allow dental treatment perform , need least two restoration local anesthesia rubber dam isolation . It estimate preliminarily sample 84 child equally divide three group : A ) Ketamine ( 4.0 mg / kg 100 mg ) + midazolam ( 0.2 mg / kg , maximum 5 mg ) intranasally ; B ) ketamine ( 4.0 mg / kg 100 mg ) + midazolam ( 0.5 mg / kg , maximum 20 mg ) orally ; C ) midazolam ( 1.0 mg / kg , maximum 20 mg ) orally . The hypothesis ketamine / midazolam combination , administer intranasally , constitutes effective sedative regime , safe cost-effective use pediatric dentistry public service . The primary endpoint behavior child . Secondary endpoint : sedative administration acceptance , procedure memory salivary cortisol level within intervention group . Additionally , evaluate : occurrence pain associate change facial expression potentially painful stimuli child sedate dental care ; caregiver paediatric dentist ' stress perception sedation ; adverse event occur administration sedative ; cost-effectiveness sedative protocol . The experimental design plan minimize systematic random error contribute high level evidence future systematic review . The outcome study potential impact public private health practice , may support institutional guideline deal theme .</detailed_description>
	<mesh_term>Dental Caries</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>American Society Anesthesiologists I ( healthy ) II ( mild control systemic disease persistent asthma ) Small risk airway obstruction ( Mallampati le 2 tonsillar hypertrophy occupy less 50 % oropharynx ) No medical history neurological cognitive change Absence facial deformity Term birth No use drug may impair cognitive function At least two teeth cavity without pulp involvement , require dental restoration local anesthesia rubber dam Positive definitely positive behavior ( Frankl et al , 1962 ) dental treatment session conduct research team</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Dental caries</keyword>
	<keyword>Moderate sedation</keyword>
</DOC>